248 related articles for article (PubMed ID: 23890927)
1. Estimated GFR and risk of hip fracture in older men: comparison of associations using cystatin C and creatinine.
Ensrud KE; Parimi N; Fink HA; Ishani A; Taylor BC; Steffes M; Cauley JA; Lewis CE; Orwoll ES;
Am J Kidney Dis; 2014 Jan; 63(1):31-9. PubMed ID: 23890927
[TBL] [Abstract][Full Text] [Related]
2. Estimated Glomerular Filtration Rate (eGFR) based on cystatin C was associated with increased risk of hip and proximal humerus fractures in women and decreased risk of hip fracture in men, whereas eGFR based on creatinine was not associated with fracture risk in both sexes: The Tromsø Study.
Nordvåg SK; Solbu MD; Melsom T; Nissen FI; Andreasen C; Borgen TT; Eriksen BO; Joakimsen RM; Bjørnerem Å
Bone; 2021 Jul; 148():115960. PubMed ID: 33864977
[TBL] [Abstract][Full Text] [Related]
3. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.
Gutiérrez OM; Sang Y; Grams ME; Ballew SH; Surapaneni A; Matsushita K; Go AS; Shlipak MG; Inker LA; Eneanya ND; Crews DC; Powe NR; Levey AS; Coresh J;
JAMA; 2022 Jun; 327(23):2306-2316. PubMed ID: 35667006
[TBL] [Abstract][Full Text] [Related]
4. Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.
Hundemer GL; White CA; Norman PA; Knoll GA; Tangri N; Sood MM; Hiremath S; Burns KD; McCudden C; Akbari A
Am J Kidney Dis; 2022 Oct; 80(4):462-472.e1. PubMed ID: 35588905
[TBL] [Abstract][Full Text] [Related]
5. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
Chen DC; Shlipak MG; Scherzer R; Bauer SR; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
JAMA Netw Open; 2022 Feb; 5(2):e2148940. PubMed ID: 35175342
[TBL] [Abstract][Full Text] [Related]
6. Assessment of creatinine and cystatin C-based eGFR equations in Chinese older adults with chronic kidney disease.
Guan C; Liang M; Liu R; Qin S; He F; Li J; Zhu X; Dai H; Fu J
Int Urol Nephrol; 2018 Dec; 50(12):2229-2238. PubMed ID: 29948865
[TBL] [Abstract][Full Text] [Related]
7. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.
Grams ME; Juraschek SP; Selvin E; Foster MC; Inker LA; Eckfeldt JH; Levey AS; Coresh J
Am J Kidney Dis; 2013 Aug; 62(2):253-60. PubMed ID: 23619125
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Estimated Glomerular Filtration Rate with Both Serum Creatinine and Cystatin C (eGFRcr-cys) versus Single Analyte (eGFRcr or eGFRcys) Using CKD-EPI and MDRD Equations in Tertiary Care Hospital Settings.
Khalid UB; Haroon ZH; Aamir M; Ain QU; Mansoor K; Jaffar SR
J Coll Physicians Surg Pak; 2020 Jul; 30(7):701-706. PubMed ID: 32811598
[TBL] [Abstract][Full Text] [Related]
9. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.
Meeusen JW; Rule AD; Voskoboev N; Baumann NA; Lieske JC
Clin Chem; 2015 Oct; 61(10):1265-72. PubMed ID: 26240296
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C and risk of hip fractures in older women.
Ensrud KE; Parimi N; Cauley JA; Ishani A; Slinin Y; Hillier TA; Taylor BC; Steffes M; Cummings SR;
J Bone Miner Res; 2013 Jun; 28(6):1275-82. PubMed ID: 23300153
[TBL] [Abstract][Full Text] [Related]
11. Combining Cystatin C and Creatinine Yields a Reliable Glomerular Filtration Rate Estimation in Older Adults in Contrast to β-Trace Protein and β2-Microglobulin.
Werner K; Pihlsgård M; Elmståhl S; Legrand H; Nyman U; Christensson A
Nephron; 2017; 137(1):29-37. PubMed ID: 28407629
[TBL] [Abstract][Full Text] [Related]
12. Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test.
Fan L; Inker LA; Rossert J; Froissart M; Rossing P; Mauer M; Levey AS
Nephrol Dial Transplant; 2014 Jun; 29(6):1195-203. PubMed ID: 24449101
[TBL] [Abstract][Full Text] [Related]
13. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
[TBL] [Abstract][Full Text] [Related]
14. Applicability of chronic kidney disease epidemiology collaboration equations in a Chinese population.
Zhang M; Chen Y; Tang L; Zhang J; Liu S; Wang S; Wei R; Zhou J; Cao X; Zhang W; Zhang J; Yang Y; Cai G; Sun X; Chen X
Nephrol Dial Transplant; 2014 Mar; 29(3):580-6. PubMed ID: 24335503
[TBL] [Abstract][Full Text] [Related]
15. Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women.
LaCroix AZ; Lee JS; Wu L; Cauley JA; Shlipak MG; Ott SM; Robbins J; Curb JD; Leboff M; Bauer DC; Jackson RD; Kooperberg CL; Cummings SR;
J Am Geriatr Soc; 2008 Aug; 56(8):1434-41. PubMed ID: 18662213
[TBL] [Abstract][Full Text] [Related]
16. GFR estimation using standardized cystatin C in kidney transplant recipients.
Masson I; Maillard N; Tack I; Thibaudin L; Dubourg L; Delanaye P; Cavalier E; Bonneau C; Kamar N; Morelon E; Moranne O; Alamartine E; Mariat C
Am J Kidney Dis; 2013 Feb; 61(2):279-84. PubMed ID: 23141866
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C and frailty in older men.
Hart A; Paudel ML; Taylor BC; Ishani A; Orwoll ES; Cawthon PM; Ensrud KE;
J Am Geriatr Soc; 2013 Sep; 61(9):1530-6. PubMed ID: 24001352
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women.
Driver TH; Scherzer R; Peralta CA; Tien PC; Estrella MM; Parikh CR; Butch AW; Anastos K; Cohen MH; Nowicki M; Sharma A; Young MA; Abraham A; Shlipak MG
AIDS; 2013 Sep; 27(14):2291-9. PubMed ID: 23669156
[TBL] [Abstract][Full Text] [Related]
20. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
